Nurul Syakima Ab Mutalib
Overview
Explore the profile of Nurul Syakima Ab Mutalib including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
231
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohd Kamal K, Ghazali A, Ab Mutalib N, Abu N, Chua E, Masre S
Heliyon
. 2024 Oct;
10(19):e38663.
PMID: 39403460
Lung cancer as the second most death cancer reported cases is becoming a major threat to the global healthcare system. With the different subtypes of lung cancer and their limited...
2.
Mohd Nippah N, Abu N, Ab Mutalib N, Alias H
Front Genet
. 2024 Jun;
15:1394523.
PMID: 38894724
Leukemia is one of the most common cancers in children; and its genetic diversity in the landscape of acute lymphoblastic leukemia (ALL) is important for diagnosis, risk assessment, and therapeutic...
3.
Ang W, Law J, Letchumanan V, Hong K, Wong S, Ab Mutalib N, et al.
Foods
. 2023 Jul;
12(13).
PMID: 37444223
A new next-generation probiotic, was first discovered in 2012 from healthy human stool and described under the phylum . is a subdominant commensal bacterium with highly heritable properties that exhibits...
4.
Abu N, Rus Bakarurraini N, Nasir S, Ishak M, Baharuddin R, Jamal R, et al.
Iran J Immunol
. 2023 Mar;
20(1):83-91.
PMID: 36932973
Background: Cancer testis antigens (CTAs) are a class of immune-stimulating antigens often overexpressed in many types of cancers. The usage of the CTAs as immunotherapy targets have been widely investigated...
5.
Azami N, Perera D, Thayan R, AbuBakar S, Sam I, Salleh M, et al.
Int J Infect Dis
. 2022 Nov;
125:216-226.
PMID: 36336246
Objectives: This study reported SARS-CoV-2 whole genome sequencing results from June 2021 to January 2022 from seven genome sequencing centers in Malaysia as part of the national surveillance program. Methods:...
6.
Baharudin R, Rus Bakarurraini N, Ismail I, Lee L, Ab Mutalib N
Int J Mol Sci
. 2022 Jul;
23(13).
PMID: 35806286
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide. Despite significant advances in the diagnostic services and patient care, several gaps remain to be addressed, from...
7.
Azami N, Abdul Murad N, Mohammed Nawi A, Salleh S, Periyasamy P, Kori N, et al.
J Infect Dev Ctries
. 2022 Jan;
15(12):1816-1824.
PMID: 35044938
Introduction: During the second wave of the coronavirus disease 19 (COVID-19) pandemic, Malaysia reported several COVID-19 clusters related to healthcare workers. Thus, addressing and understanding the risk of exposure in...
8.
Amir Hashim N, Ab-Rahim S, Wan Ngah W, Nathan S, Ab Mutalib N, Sagap I, et al.
Bioimpacts
. 2021 Jan;
11(1):33-43.
PMID: 33469506
The serum metabolomics approach has been used to identify metabolite biomarkers that can diagnose colorectal cancer (CRC) accurately and specifically. However, the biomarkers identified differ between studies suggesting that more...
9.
Chew S, Tan L, Law J, Pusparajah P, Goh B, Ab Mutalib N, et al.
Cancers (Basel)
. 2020 Aug;
12(8).
PMID: 32823729
Colorectal cancer (CRC) is a global public health issue which poses a substantial humanistic and economic burden on patients, healthcare systems and society. In recent years, intestinal dysbiosis has been...
10.
Rus Bakarurraini N, Ab Mutalib N, Jamal R, Abu N
Vaccines (Basel)
. 2020 Jul;
8(3).
PMID: 32664247
Over the last few decades, major efforts in cancer research and treatment have intensified. Apart from standard chemotherapy approaches, immunotherapy has gained substantial traction. Personalized immunotherapy has become an important...